Biotech & MedTech
-
Thomas Smeenk of Hemostemix talks about market reaction to successful litigation settlement
In this InvestorIntel interview with host Stephen Lautens, Hemostemix Inc.’s (TSXV: HEM | OTCQB: HMTXF) Co-Founder, President and…
-
Nanotechnology value hunters look at Sixth Wave Innovations
After the last few days and weeks, it seems almost pointless talking about any company that is publicly…
-
Anthony Tennyson of Awakn Life Sciences talks about their portfolio of revolutionary therapeutics and clinics to treat addiction
In this InvestorIntel interview with host Tracy Weslosky, Awakn Life Sciences Corp.’s (NEO: AWKN | OTCQB: AWKNF) Co-Founder &…
-
Hemostemix’s stem cell therapy pursues ‘Your Fountain of Youth’
What’s a company worth to investors that could improve numerous medical conditions related to ischemia (lack of blood…
-
Steve Saviuk on Valeo Pharma’s TSX Listing and Q1-22 revenues of $4.2 million, up 128% over Q1-21
In a recent InvestorIntel interview, Tracy Weslosky interviews Valeo Pharma Inc.’s (TSX: VPH | OTCQB: VPHIF) Founder, CEO…
-
Valeo Pharma’s rocketing growth in sales points to positive cash flow this year
Stock market investors love companies that can quickly expand and rapidly grow their revenues. The very best of…
-
NuGen Medical Devices provide easy and painless injections without needles
Having spent far too much time over the last two years watching Netflix, reading fiction and playing video…
-
How NASDAQ listed Zentek is a ‘wow’ company with enormous potential to tap into several multi-billion dollar industries.
Every once in a while investors will come across a ‘wow’ company. This is a company that just…
-
Dr Jon Gluckman provides an update on Sixth Wave Innovations’ pathogen detection technologies
In a recent InvestorIntel interview, Tracy Weslosky spoke with Dr. Jon Gluckman, President and CEO of Sixth Wave Innovations…
